BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20633739)

  • 21. The treatment of depression: prescribing practices of primary care physicians and psychiatrists.
    Olfson M; Klerman GL
    J Fam Pract; 1992 Dec; 35(6):627-35. PubMed ID: 1360490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.
    Sung SK; Lee SG; Lee KS; Kim DS; Kim KH; Kim KY
    Clin Ther; 2009 Jun; 31(6):1309-20. PubMed ID: 19695396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder.
    Amsterdam JD; Williams D; Michelson D; Adler LA; Dunner DL; Nierenberg AA; Reimherr FW; Schatzberg AF
    Neuropsychobiology; 2009; 59(4):227-33. PubMed ID: 19571597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia.
    Mortensen EM; Restrepo M; Anzueto A; Pugh J
    Am J Med; 2004 Nov; 117(10):726-31. PubMed ID: 15541321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).
    Wade AG; Schlaepfer TE; Andersen HF; Kilts CD
    J Psychiatr Res; 2009 Feb; 43(5):568-75. PubMed ID: 18954875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Care concordant with guidelines predicts decreased long-term mortality in patients with unstable angina pectoris and non-ST-elevation myocardial infarction.
    Allen LA; O'Donnell CJ; Giugliano RP; Camargo CA; Lloyd-Jones DM
    Am J Cardiol; 2004 May; 93(10):1218-22. PubMed ID: 15135692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinician- and organization-level factors in the adoption of evidence-based care for depression in primary care.
    Henke RM; McGuire TG; Zaslavsky AM; Ford DE; Meredith LS; Arbelaez JJ
    Health Care Manage Rev; 2008; 33(4):289-99. PubMed ID: 18815494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project.
    Dennehy EB; Suppes T; Rush AJ; Miller AL; Trivedi MH; Crismon ML; Carmody TJ; Kashner TM
    Psychol Med; 2005 Dec; 35(12):1695-706. PubMed ID: 16194283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adequacy of continuation and maintenance treatments for major depression in Japan.
    Fujita A; Azuma H; Kitamura T; Takahashi K; Akechi T; Furukawa TA
    J Psychopharmacol; 2008 Mar; 22(2):153-6. PubMed ID: 18208923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of depression--newer pharmacotherapies.
    Mulrow CD; Williams JW; Trivedi M; Chiquette E; Aguilar C; Cornell JE; Badgett R; Noël PH; Lawrence V; Lee S; Luther M; Ramirez G; Richardson WS; Stamm K
    Psychopharmacol Bull; 1998; 34(4):409-795. PubMed ID: 10513454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between chronic illness complexity and receipt of evidence-based depression care.
    Jordan N; Sohn MW; Bartle B; Valenstein M; Lee Y; Lee TA
    Med Care; 2014 Mar; 52 Suppl 3():S126-31. PubMed ID: 24561751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choosing a second generation antidepressant for treatment of major depressive disorder.
    Lester H; Gilbody S
    BMJ; 2012 Feb; 344():e1014. PubMed ID: 22334542
    [No Abstract]   [Full Text] [Related]  

  • 33. Receiving guideline-concordant pharmacotherapy for major depression: impact on ambulatory and inpatient health service use.
    Sewitch MJ; Blais R; Rahme E; Bexton B; Galarneau S
    Can J Psychiatry; 2007 Mar; 52(3):191-200. PubMed ID: 17479528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Practice guideline for the treatment of mood disorders].
    Higuchi T
    Nihon Rinsho; 2007 Sep; 65(9):1627-32. PubMed ID: 17876985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of Outpatient Depression Treatment in Patients With Comorbid Substance Use Disorder.
    Coughlin LN; Pfeiffer P; Ganoczy D; Lin LA
    Am J Psychiatry; 2021 May; 178(5):414-423. PubMed ID: 33115247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of depression care on outcomes in COPD patients with depression.
    Jordan N; Lee TA; Valenstein M; Pirraglia PA; Weiss KB
    Chest; 2009 Mar; 135(3):626-632. PubMed ID: 19017894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guideline adherence of antidepressant treatment in outpatients with major depressive disorder: a naturalistic study.
    Herzog DP; Wagner S; Ruckes C; Tadic A; Roll SC; Härter M; Lieb K
    Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):711-721. PubMed ID: 28421334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of general medical and psychiatric comorbidities with receipt of guideline-concordant care for depression.
    Ettner SL; Azocar F; Branstrom RB; Meredith LS; Zhang L; Ong MK
    Psychiatr Serv; 2010 Dec; 61(12):1255-9. PubMed ID: 21123412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder.
    Bhattacharjee S; Lee JK; Vadiei N; Patanwala AE; Malone DC; Knapp SM; Lo-Ciganic WH; Burke WJ
    Neuropsychiatr Dis Treat; 2020; 16():1433-1450. PubMed ID: 32606697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simplifying care for complex patients.
    Bayliss EA
    Ann Fam Med; 2012; 10(1):3-5. PubMed ID: 22230824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.